December 22, 2022

Uncontrolled Substances, Part 4: The Reckoning

by The Journal

Two years after launching, Cerebral had become a star in the telemedicine business space. The company had attracted tens of thousands of patients and was valued at close to $5 billion. CEO Kyle Robertson had big plans for the startup, but this spring, those plans started to crumble. WSJ’s Rolfe Winker and Khadeeja Safdar started reporting on Cerebral. Their reporting would lead to federal investigations and major changes for the company.


Further Reading:

- The Failed Promise of Online Mental-Health Treatment 


Further Listening:

- The Journal: Uncontrolled Substances, Part 1: Subscribe and Prescribe 

- The Journal: Uncontrolled Substances, Part 2: Adderall 

- The Journal: Uncontrolled Substances, Part 3: Anthony 

Where to Listen